Buprenorphine + Naloxone 8/2mg, 2/0.5mg sublingual tablets (FDC)

Buprenorphine + Naloxone 8/2mg, 2/0.5mg sublingual tablets (FDC)
Product Description

Intro

Dossier:
Indication:
Formulation: 

SMB Laboratories SA

  • Country/Region:
    Belgium
  • On CPHI since:
    2015
Company types
Manufacturer/Innovator
Specifications

SMB Laboratories SA

  • Country/Region:
    Belgium
  • On CPHI since:
    2015
Company types
Manufacturer/Innovator

More Products from SMB Laboratories SA (24)

SMB Laboratories SA resources (1)